|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 409/10 | |
| A61P 3/10 | |||
| A61P 27/02 | |||
| A61P 25/00 |
| (11) | Number of the document | 3239149 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15871510.2 |
| Date of filing the European patent application | 2015-03-27 | |
| (97) | Date of publication of the European application | 2017-11-01 |
| (45) | Date of publication and mention of the grant of the patent | 2021-01-27 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/CN2015/075180 |
| Date | 2015-03-27 |
| (87) | Number | WO 2016/101432 |
| Date | 2016-06-30 |
| (30) | Number | Date | Country code |
| 201410820560 | 2014-12-25 | CN |
| (72) |
WANG, Fei, CN
ZHANG, Jian, CN
LIN, Meng, CN
TANG, Yuanfu, CN
CHEN, Hao, CN
LEI, Huangshu, CN
|
| (73) |
Chongqing Pharmaceutical Industrial Research Institute Co. Ltd.,
No.565 Tushan Road Nan`an District, Chongqing 400061,
CN
|
| (54) | CRYSTAL FORM I OF CANAGLIFLOZIN AND PREPARATION METHOD THEREOF |
| CRYSTAL FORM I OF CANAGLIFLOZIN AND PREPARATION METHOD THEREOF |